PharmTech Talk

Feb 17, 2017
The trends in the year 2017 will present the industry with new challenges, and companies will be able to meet them successfully if they focus on the issues at hand.
Feb 13, 2017
Drug companies are pushing Congress to action on funding for FDA programs and staff to expedite drug reviews and approvals.
Feb 02, 2017
Pharmaceutical Technology
Reducing regulatory roadblocks requires more than the stroke of a pen.
Feb 01, 2017
In promising to expedite and simplify the FDA approval process, President Donald Trump fails to take account of industry's appreciation of an efficient, rigorous FDA regulatory system.
Jan 25, 2017
FDA’s Office of Regional Affairs aims to implement Program Alignment initiative by May 15, 2017.
Jan 11, 2017
FDA published a flurry of guidance documents in late 2016.
Dec 08, 2016
Congress enacted the 21st Century Cures legislation, which shores FDA operations and supports biomedical research at the National Institutes of Health.
Dec 01, 2016
The House-approved 21st Century Cures legislation supports initiatives for medical research, drug development, and faster approvals, but comes up short on actual appropriations.
Nov 18, 2016
Biopharma proponents argue for FDA resources, Cures legislation, and science-based drug regulation.
Nov 09, 2016
What’s ahead for the healthcare and pharmaceutical industries?
native1_300x100
lorem ipsum